Morrisons Distribution Centre Worker Diagnosed with Meningitis in Growing Canterbury Outbreak
A staff member at a Morrisons distribution centre has contracted meningitis after visiting Club Chemistry in Canterbury, as health officials confirm the outbreak in Kent has now reached a total of twenty-seven cases. The supermarket chain has verified that an employee at its Sittingbourne distribution centre is currently receiving medical treatment following the diagnosis, with the specific strain of the illness still under investigation by authorities.
Outbreak Escalates to 27 Cases with Two Fatalities Confirmed
The UK Health Security Agency (UKHSA) reported that as of 5pm on March 18, fifteen laboratory-confirmed cases have been identified, with an additional twelve suspected infections still being examined. Tragically, two individuals have lost their lives due to the outbreak, although no new deaths have been recorded since the last official update. The situation remains fluid as health teams work to contain the spread and identify all potential contacts.
Supermarket Chain Implements Safety Protocols and Maintains Operations
A Morrisons spokesperson stated, "We can confirm that a colleague at our Sittingbourne distribution centre visited Club Chemistry and subsequently contracted meningitis. He is currently receiving treatment and we are in close touch with his family." The company emphasized that they are following all government guidance rigorously, with the distribution site continuing normal operations while closely monitoring the developing situation to ensure staff safety and public health.
Mass Vaccination Drive Underway at University of Kent Campus
In response to the escalating outbreak, health authorities administered six hundred meningitis B vaccines yesterday at the University of Kent, with students queuing again today outside the campus sports centre to receive their vaccinations. UKHSA regional deputy director for the South East, Trish Mannes, highlighted the importance of vaccination while noting its limitations, stating, "Two doses of the MenB vaccine helps protect individuals against meningococcal B disease."
Manness further explained, "It is important to know that the MenB vaccine does not protect against all strains of meningococcal disease, nor against all infections that can cause meningitis. It also does not prevent the bacteria from being carried and spread in the community."
Public Health Officials Urge Vigilance and Prompt Medical Attention
Health authorities are strongly advising the public to remain aware of meningitis symptoms and seek immediate medical assistance if any signs appear. Mannes emphasized, "It is therefore still hugely important that people are aware of the signs and symptoms of invasive meningococcal disease, and that they seek immediate medical attention if they or anyone they know develops these signs and symptoms."
Students at the University of Kent who have returned home but are eligible for vaccination are being instructed to contact their local GP for advice and appropriate treatment. Preventative antibiotics are also being recommended for those identified as potential contacts, with health officials stressing the importance of taking them promptly to reduce transmission risks.
